The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage (CONSCIOUS-1): Randomized, Double-Blind, Placebo-Controlled Phase 2 Dose-Finding Trial
Open accessAbstract
Background and Purpose— This randomized, double-blind, placebo-controlled, dose-finding study assessed efficacy and safety of 1, 5, and 15 mg/h intravenous clazosentan, an endothelin receptor antagonist, in preventing vasospasm after aneurysmal subarachnoid hemorrhage. Methods— Patients (n=413) were randomized to placebo or clazosentan beginning within 56 hours and continued up to 14 days after initiation of treatment. The primary end point was moderate or severe angiographic vasospasm based on centrally read, blinded evaluation of digital subtraction angiography at baseline and 7 to 11 days postsubarachnoid hemorrhage. A morbidity/mortality end point, including all-cause mortality, new cerebral infarct from any cause, delayed ischemic neurological deficit due to vasospasm, or use of rescue therapy, was evaluated by local assessment. Clinical outcome was assessed by the extended Glasgow Outcome Scale at 12 weeks. Results— Moderate or severe vasospasm was reduced in a dose-dependent fashion from 66% in the placebo group to 23% in the 15 mg/h clazosentan group (risk reduction, 65%; 95% CI, 47% to 78%; P <0.0001). No significant effects were seen on secondary end points. Post hoc analysis using a centrally assessed morbidity/mortality end point that included death and rescue therapy but only cerebral infarcts and delayed ischemic neurological deficit due to vasospasm on central review showed a trend toward improvement with clazosentan (37%, 28%, and 29% in the 1, 5, and 15 mg/h groups versus 39% in the placebo group, nonsignificant). Clazosentan was associated with increased rates of pulmonary complications, hypotension, and anemia. Conclusions— Clazosentan significantly decreased moderate and severe vasospasm in a dose-dependent manner and showed a trend for reduction in vasospasm-related morbidity/mortality in patients with aneurysmal subarachnoid hemorrhage when centrally assessed. Overall, the adverse effects were manageable and not considered serious.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measurements of acute cerebral infarction: a clinical examination scale.
Brott, T., Adams, H. P., Olinger, C. P., Marler, J. R., Barsan, W. G., Biller, J., Spilker, J., Holleran, R., Eberle, R., & Hertzberg, V (1989) · Stroke · doi:10.1161/01.str.20.7.864 · Cited by 5,911
WILSON, J. T. L., PETTIGREW, L. E. L., & TEASDALE, G. M. (1998) · Journal of Neurotrauma · doi:10.1089/neu.1998.15.573 · Cited by 2,386
Kassell, N. F., Torner, J. C., Haley, E. C., Jane, J. A., Adams, H. P., Kongable, G. L., & _, _. (1990) · Journal of Neurosurgery · doi:10.3171/jns.1990.73.1.0018 · Cited by 2,112
Self-citation(1988) · Journal of Neurosurgery · doi:10.3171/jns.1988.68.6.0985 · Cited by 1,196
Pickard, J. D., Murray, G. D., Illingworth, R. D., Shaw, M. D. M., Teasdale, G. M., Foy, P. M., Humphrey, P. R. D., Lang, D. A., Nelson, R. J., Richards, P., et al. (1989) · CRC Press eBooks · doi:10.1136/bmj.298.6674.636 · Cited by 1,144
Aneurysmal Subarachnoid Hemorrhage
Suarez, J. I., Tarr, R. W., & Selman, W. R. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052732 · Cited by 986
Calcium antagonists for aneurysmal subarachnoid haemorrhage
Dorhout Mees, S., Rinkel, G. J., Feigin, V. L., Algra, A., van den Bergh, W. M., Vermeulen, M., & van Gijn, J. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000277.pub3 · Cited by 758
Drake, C. G. (1988) · Cited by 575
Petruk, K. C., West, M., Mohr, G., Weir, B. K. A., Benoit, B. G., Gentili, F., Disney, L. B., Khan, M. I., Grace, M., Holness, R. O., et al. (1988) · Journal of Neurosurgery · doi:10.3171/jns.1988.68.4.0505 · Cited by 549
Computed tomographic diagnosis of intraventricular hemorrhage. Etiology and prognosis.
Graeb, D. A., Robertson, W. D., Lapointe, J. S., Nugent, R. A., & Harrison, P. B. (1982) · Radiology · doi:10.1148/radiology.143.1.6977795 · Cited by 459
Grading the amount of blood on computed tomograms after subarachnoid hemorrhage.
Hijdra, A., Brouwers, P. J., Vermeulen, M., & van Gijn, J. (1990) · Stroke · doi:10.1161/01.str.21.8.1156 · Cited by 429
Kassell, N. F., Haley, E. C., Apperson-Hansen, C., Alves, W. M., & _, _. (1996) · Journal of Neurosurgery · doi:10.3171/jns.1996.84.2.0221 · Cited by 394
Self-citationAcute hydrocephalus after aneurysmal subarachnoid hemorrhage
van Gijn, J., Hijdra, A., Wijdicks, E. F. M., Vermeulen, M., & van Crevel, H. (1985) · Journal of neurosurgery · doi:10.3171/jns.1985.63.3.0355 · Cited by 389
Acute Hydrocephalus after Aneurysmal Subarachnoid Hemorrhage
Milhorat, T. H. (1990) · Annual Review of Hydrocephalus · doi:10.1007/978-3-662-11152-9_101 · Cited by 344
Magnesium Sulfate in Aneurysmal Subarachnoid Hemorrhage: A Randomized Controlled Trial
van den Bergh, W. M. (2005) · Stroke · doi:10.1161/01.str.0000160801.96998.57 · Cited by 321
Kalra, P. R., Moon, J. C. C., & Coats, A. J. S. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00182-1 · Cited by 293
PREDICTORS OF CEREBRAL INFARCTION IN PATIENTS WITH ANEURYSMAL SUBARACHNOID HEMORRHAGE
Ferguson, S., & Macdonald, R. L. (2007) · Neurosurgery · doi:10.1227/01.neu.0000255396.23280.31 · Cited by 252
Self-citationLanzino, G., Kassell, N. F., & _, _. (1999) · Journal of Neurosurgery · doi:10.3171/jns.1999.90.6.1018 · Cited by 219
Self-citationEndothelin and the production of cerebral vasospasm in dogs
Asano, T., Ikegaki, I., Suzuki, Y., Satoh, S.-I., & Shibuya, M. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92258-4 · Cited by 187
Roux, S., Breu, V., Giller, T., Neidhart, W. L., Ramuz, H., Coassolo, P., Clozel, J., & Clozel, M. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37130-7 · Cited by 116
Self-citationEvidence-based cerebral vasospasm management
Weyer, G. W., Nolan, C. P., & Macdonald, R. L. (2006) · Neurosurgical FOCUS · doi:10.3171/foc.2006.21.3.8 · Cited by 92
Self-citation
Cited by
Mechanical ventilation guided by esophageal pressure in acute lung injury.
Talmor, D., Sarge, T., Malhotra, A., O'Donnell, C. R., Ritz, R., Lisbon, A., Novack, V., & Loring, S. H. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708638 · Cited by 1,149
Delayed neurological deterioration after subarachnoid haemorrhage
Macdonald, R. L. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.246 · Cited by 887
Self-citationLauritzen, M., Dreier, J. P., Fabricius, M., Hartings, J. A., Graf, R., & Strong, A. J. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.191 · Cited by 782
Defining Vasospasm After Subarachnoid Hemorrhage: What Is the Most Clinically Relevant Definition?
Frontera, J. A., Fernandez, A., Schmidt, J. M., Claassen, J., Wartenberg, K. E., Badjatia, N., Connolly, E. S., & Mayer, S. A. (2009) · Stroke · doi:10.1161/strokeaha.108.544700 · Cited by 586
Self-citationThe importance of early brain injury after subarachnoid hemorrhage
Sehba, F. A., Hou, J., Pluta, R. M., & Zhang, J. H. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.02.003 · Cited by 571
Metadata
- Authors
- Macdonald, R. L., Kassell, N. F., Mayer, S., Ruefenacht, D., Schmiedek, P., Weidauer, S., Frey, A., Roux, S., & Pasqualin, A.
- Venue
- Stroke
- Published
- 2008-11
- Volume
- 39
- Issue
- 11
- Pages
- 3015-3021
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2150982420
- Cited by
- 648
- References
- 21
- FWCI
- 25.73
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.